GeneDx Accounts Payable from 2010 to 2024

WGSWW Stock   0.17  0.02  13.33%   
GeneDx Holdings Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 9.7 M in 2024. Accounts Payable is the amount GeneDx Holdings Corp owes to suppliers or vendors for products or services received but not yet paid for. It represents GeneDx Holdings' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
10.2 M
Current Value
9.7 M
Quarterly Volatility
9.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Net Interest Income of 1.2 M, Interest Income of 3.1 M or Depreciation And Amortization of 31.3 M, as well as many indicators such as Price To Sales Ratio of 0.31, Dividend Yield of 0.0 or PTB Ratio of 0.52. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.
  
Check out the analysis of GeneDx Holdings Correlation against competitors.

Latest GeneDx Holdings' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of GeneDx Holdings Corp over the last few years. An accounting item on the balance sheet that represents GeneDx Holdings obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of GeneDx Holdings Corp are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. GeneDx Holdings' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeneDx Holdings' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Very volatile
   Accounts Payable   
       Timeline  

GeneDx Accounts Payable Regression Statistics

Arithmetic Mean26,985,407
Geometric Mean25,155,719
Coefficient Of Variation35.08
Mean Deviation4,898,558
Median26,737,000
Standard Deviation9,467,231
Sample Variance89.6T
Range36.3M
R-Value(0.08)
Mean Square Error95.8T
R-Squared0.01
Significance0.77
Slope(178,023)
Total Sum of Squares1254.8T

GeneDx Accounts Payable History

20249.7 M
202310.2 M
202246 M
202144.7 M

About GeneDx Holdings Financial Statements

GeneDx Holdings investors use historical fundamental indicators, such as GeneDx Holdings' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeneDx Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable10.2 M9.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.